Can you take HRT with multiple sclerosis? Often, yes. MS is not on the FDA estrogen label's list of reasons not to use it, and MS charities and specialist centers say HRT can be used by women with MS when it suits their own health risks. But HRT is not a treatment for MS, the research on MS itself is limited, and limited mobility can raise blood clot risk. Plan it with your neurologist in the loop.
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
What we actually verified · Last verified October 2026
What we read on October 28, 2026:
- The FDA-approved label for estradiol tablets (Estrace) on DailyMed, including its contraindications and blood clot warnings.
- The FDA-approved label for Aubagio (teriflunomide) on DailyMed, in its section on estrogen-containing products.
- The Menopause Society's 2022 hormone therapy position statement.
- The Cleveland Clinic Mellen Center's clinical guidance on managing menopause in women with MS.
- The MS Society (UK) guide to menopause and MS and its women's health booklet.
- Studies on MS and menopause, including a 2025 MSBase cohort in JAMA Neurology, a 2022 Danish nationwide registry study of hormone therapy, a 2022 randomized pilot trial of Duavee in women with MS, and a 2016 estriol trial in The Lancet Neurology.
What we did not do: we are not clinicians, we did not treat anyone, and we did not interview patients. Nothing here is advice to start, stop or change any medicine. Your neurologist and your menopause clinician are the people who can make that call with you.
Our commercial interest: we may earn a commission if you start care with a provider featured in Find My HRT Path. No provider is linked on this page, and that never changes what we report. How we make money.
How we judge any option (our Verification Standard, in this order): 1) clinical legitimacy, 2) care quality, 3) medication fit, 4) price transparency, 5) access. Read the full methodology.
Jump to: Quick answer by situation · Is MS a contraindication? · Does HRT affect MS? · Menopause or MS symptoms? · Blood clots and mobility · MS medicines · Pill, patch or vaginal? · Bones · Non-hormonal options · Questions for your clinicians · Online care · FAQ
Can you take HRT with multiple sclerosis? A quick answer for your situation
Most women with MS can at least discuss HRT, because MS by itself does not rule it out. What changes the answer is how well you can move around, your personal blood clot and heart risk, which MS medicines you take, and whether you have a standard reason HRT would be unsafe for anyone. Find your situation below.
| Your situation | What the evidence and guidance point to | Who to talk with first |
|---|---|---|
| Walking independently, bothersome hot flashes or night sweats, no estrogen contraindications | HRT can be a reasonable option to discuss. MS is not a listed contraindication on the estradiol label. | A menopause clinician, with your neurologist kept in the loop |
| Using a wheelchair or mostly not walking | Immobility raises blood clot risk. The Cleveland Clinic notes some women with MS may be at higher clot risk because of mobility, which can change whether and how systemic HRT is used. | Both clinicians together, before starting |
| Mainly vaginal dryness, painful sex or bladder irritation | Low-dose vaginal estrogen is described by the Cleveland Clinic as effective and considered safe in MS. | Your menopause clinician or gynecologist |
| You take teriflunomide (Aubagio) | Its label says it may raise blood levels of ethinylestradiol, an estrogen used in birth control pills. HRT usually uses estradiol, which the label does not address. | Your neurologist, so the HRT type and dose take this into account |
| You've had a relapse recently or symptoms are changing | Changing symptoms need an MS review first, so a relapse isn't mistaken for menopause, or the other way round. | Your neurologist or MS nurse |
| Early menopause after stem cell transplant or chemotherapy for MS | These treatments commonly cause early menopause. Early menopause has its own HRT considerations. | Your MS team and a menopause specialist |
| You've had breast cancer, a blood clot, stroke, liver disease or unexplained bleeding | These are standard estrogen contraindications for every woman, with or without MS. | Your doctor in person; see who should not take HRT |
The right online menopause care isn't the same for every woman — it depends on your symptoms, what you've already tried, your age, your state and your health history. Some situations belong with an in-person clinician first. Use The HRT Index's Find My HRT Path tool to explore a featured care option for your situation — and to flag when online care isn't the right starting point — before your first consult.
Is multiple sclerosis a contraindication for HRT?
No. MS does not appear on the contraindication list in the FDA-approved label for estradiol tablets. The listed reasons not to use estrogen are pregnancy, allergy to the ingredients, liver disease, a recent stroke or heart attack, a current or past blood clot in the legs or lungs, a known clotting disorder, breast cancer, other estrogen-dependent cancers, and unexplained vaginal bleeding (estradiol tablets label, DailyMed).
MS organizations say the same thing in plain terms. The MS Society (UK) says HRT tablets, patches, gels and implants "can be safely used by women with MS," and that there's no reason to think MS affects how HRT works (MS Society UK). The Cleveland Clinic's MS center says hormone therapy is "generally" considered safe for women with MS and should be used when indicated, after the usual contraindications are checked (Cleveland Clinic).
The standard HRT safety rules still apply to you. The Menopause Society's 2022 position statement says that for healthy women with bothersome symptoms who are under 60 or within 10 years of menopause, the benefits of hormone therapy generally outweigh the risks (The Menopause Society, 2022). Our guide to HRT contraindications covers those rules in full.
Does HRT make MS better or worse?
Nobody knows for sure. The studies so far show no clear effect of menopausal HRT on MS disability, one registry found slightly more relapses in current users during an older treatment era, and no large trial has tested it. HRT should be seen as a treatment for menopause symptoms, not a treatment for MS.
What the studies on HRT found
- Danish nationwide registry (2022): among 3,325 women with MS, 333 had used hormone therapy. The study found no link between hormone therapy and disability progression, especially with under 5 years of use, though there was a trend toward more risk with longer use. Current users had about a 20% higher risk of recurrent relapses, which the authors say was driven by 1996–2005, before high-efficacy MS medicines were common. They estimated this as about one extra relapse per 4 years of use (Kopp et al., 2022).
- Duavee pilot trial (2022): 24 women with MS and hot flashes were randomly given Duavee (conjugated estrogens with bazedoxifene) or a placebo for 2 months. Hot flash interference scores were lower with Duavee, but the difference was not statistically significant. The trial was built to test feasibility, not whether HRT changes MS (Bove et al., 2022).
- An expert debate (2024): a Multiple Sclerosis Journal article arguing against routine HRT for all women with MS concluded there is no evidence HRT helps MS disease activity, and that the decision should be individualized (Multiple Sclerosis Journal, 2024).
What about estriol?
You may read that estrogen reduced MS relapses. That research is about estriol, a pregnancy estrogen, not standard menopausal HRT. In a 2016 trial of 164 women aged 18 to 50 with relapsing MS, adding 8 mg of oral estriol to glatiramer acetate gave 0.25 relapses per year versus 0.37 with placebo (Voskuhl et al., Lancet Neurology, 2016). Those were premenopausal women in a phase 2 trial, so the result can't be carried over to HRT after menopause, and estriol is not an FDA-approved MS treatment.
Does menopause itself make MS worse?
The evidence is mixed. A 2015 study suggested disability might worsen a bit faster after menopause, but more recent studies haven't confirmed it, according to the MS Society. The largest recent study, a 2025 analysis of 987 women with relapse-onset MS in the MSBase registry, found menopause was not linked with a higher risk of confirmed disability progression or secondary progressive MS (Menopause impact on MS disability progression, JAMA Neurology, 2025).
Is it menopause or MS? Why the symptoms are hard to tell apart
Many menopause symptoms look like MS symptoms. The Cleveland Clinic lists the overlap as brain fog and memory problems, fatigue, mood changes, poor sleep, sexual problems and bladder issues. That makes it easy to blame a new symptom on the wrong cause.
Heat matters too. The MS Society notes that some women say hot flashes make their fatigue and bladder symptoms flare until they cool down, and that feeling hot can bring on MS symptoms whatever your hormone levels are. That's one reason treating hot flashes can matter more for women with MS.
What helps:
- Keep a symptom diary for a few weeks, noting hot flashes, sleep, fatigue, bladder symptoms and your cycle if you still have one. The Cleveland Clinic suggests diaries and questionnaires to separate the two.
- Don't assume a new or worsening neurological symptom is menopause. New weakness, numbness, vision changes or balance problems need your MS team.
- Ask about both at once. Our perimenopause symptoms checklist can help you list what to bring up. For thinking and memory changes, see HRT and brain fog.
Why blood clots and mobility matter most
For many women with MS, blood clot risk is the biggest practical question. Estrogen pills raise the risk of clots in the legs and lungs, and the estradiol label lists a current or past clot as a reason not to use it. Not being able to walk much is a separate clot risk. The Cleveland Clinic notes that some women with MS may be at higher clot risk because of their mobility. The MS Society's women's health booklet says the same: if your mobility is severely limited, HRT may not be suitable.
That doesn't automatically rule HRT out, but it's a reason to:
- Tell your clinician honestly how much you walk each day and whether you use a wheelchair.
- Ask whether a patch or gel would be a better fit than a pill. In general, transdermal estrogen appears to carry a lower clot risk than oral estrogen. See HRT and blood clots and oral vs. transdermal estrogen.
- Mention other clot risks too, such as smoking, recent surgery, a family history of clots or long periods without moving.
The Cleveland Clinic also advises screening for osteoporosis, cancer and heart disease risk in women with MS at midlife, because both MS and menopause raise these risks. Those checks feed into the HRT decision.
Do MS medicines interact with HRT?
Mostly no, based on what's known. The Cleveland Clinic says current evidence does not suggest significant interactions between MS disease-modifying therapies and hormone therapy, though it says "vigilance is warranted." One label note is worth knowing.
| MS medicine | What the label or guidance says | What to raise with your clinician |
|---|---|---|
| Teriflunomide (Aubagio) | The label says it may increase exposure to ethinylestradiol and levonorgestrel, the hormones in some birth control pills, and to consider the type or dose of contraceptive used with it (Aubagio label, DailyMed). HRT usually uses estradiol, and the label does not address it. | Whether this affects the type or dose of HRT you'd use |
| Other disease-modifying therapies | Current evidence does not suggest significant interactions with hormone therapy, per the Cleveland Clinic. | Share your full list anyway, including infusions |
| Steroids for relapses | Repeated steroid courses are a known osteoporosis risk. | Whether you need a bone density scan, and how HRT fits your bone plan |
| Medicines for spasticity, bladder, pain or mood | We did not review each one for this page. | Bring every medicine and supplement to your menopause visit |
Does it matter if HRT is a pill, patch, gel or vaginal cream?
It can. The route matters mainly because of blood clot risk and because of which symptoms you want to treat.
- Pills (oral estradiol): these pass through the liver first and carry a higher clot risk than patches or gels in general studies.
- Patches and gels (transdermal estradiol): these skip the first pass through the liver. They're often discussed when clot risk is a concern.
- Low-dose vaginal estrogen: this puts much less estrogen into the blood. The Cleveland Clinic calls it effective for vaginal and urinary symptoms of menopause and considered safe in women with MS. Sexual problems are very common in MS, at 40% to over 75% in the studies the Cleveland Clinic cites, so this is worth raising. See our guide to vaginal estrogen.
If you still have a uterus and use estrogen pills, patches or gels, you'll also need a progestogen to protect the lining of the uterus. That's standard for every woman, not specific to MS.
HRT and bone health in MS
Bone protection is a real reason HRT comes up for women with MS. The Cleveland Clinic says both MS and menopause raise osteoporosis risk, and the MS Society notes HRT can reduce further bone loss in women at risk. Steroid courses, less weight-bearing activity and a higher fall risk can all add up. Ask whether you should have a bone density scan, and whether HRT or another bone medicine makes sense for you. Our page on online HRT for osteoporosis covers the general picture.
What if HRT isn't right for you?
There are non-hormonal options. The Cleveland Clinic lists SSRIs and SNRIs, gabapentin and paroxetine for hot flashes, and notes these may also help with mood and sleep problems, which are common in MS. For vaginal dryness and painful sex, it lists non-hormonal moisturizers, ospemifene and prasterone.
Some of these medicines can cause drowsiness or dizziness, which matters if you already have fatigue or balance problems, so your neurologist should know about them too. Our overview of non-hormonal hot flash medication online compares the options.
What should you ask your neurologist and menopause clinician?
The best plan is one your neurologist and your menopause clinician both know about. Bring these questions, and write the answers down.
For your neurologist or MS nurse:
- Could any of my recent symptoms be menopause rather than MS, or the other way round?
- Does my mobility or any past clot make systemic HRT riskier for me?
- Does my disease-modifying therapy affect which HRT I should use?
- Have my steroid courses raised my risk for osteoporosis, and should I have a bone scan?
- If HRT isn't right, which non-hormonal options fit with my MS symptoms?
For your menopause clinician:
- Do I have any of the standard reasons not to take estrogen?
- Given my mobility, would a patch, gel or vaginal product make more sense than a pill?
- If I have a uterus, which progestogen would you suggest?
- How will we tell whether HRT is helping my hot flashes, sleep and fatigue?
- Will you share notes with my neurologist if I ask?
Can you get HRT online if you have MS?
You can, if your MS is being managed, your neurologist knows the plan, and the online service takes a full history, including how much you can move around and every medicine you take. Online care is a poor starting point if you're having a relapse or new neurological symptoms, if you've had a blood clot, or if you can't easily get to in-person checks such as blood pressure readings and mammograms.
What to look for in any service:
- It asks about your MS, your mobility, any past clots and every medicine you take.
- A licensed clinician reviews your history before prescribing anything.
- It offers patches, gels and vaginal options, not only pills.
- It offers follow-up visits and will send records to your neurologist if you ask.
Our guide to whether online HRT is safe covers the general checks. If you'd like help sorting out which kind of care fits your situation, The HRT Index's Find My HRT Path tool asks about your symptoms, what you've tried, your age, your state and your health history. It then shows a featured care option, or tells you when in-person care is a better place to start. It's free, takes about 60 seconds and needs no email. It is not a diagnosis or a prescription decision.
Frequently asked questions
Can you take HRT with multiple sclerosis?
Often, yes. MS is not a listed contraindication on the FDA estradiol label, and the MS Society and the Cleveland Clinic say HRT can be used by women with MS when it suits their health risks. The main extra questions are mobility and blood clot risk, and your neurologist should know the plan.
Does HRT help MS symptoms?
It hasn't been proven. HRT can ease hot flashes, night sweats, poor sleep and vaginal dryness, and some women find that helps fatigue and bladder symptoms that heat makes worse. But there's no good evidence that HRT changes MS relapses or disability.
Can HRT cause an MS relapse?
There's no clear evidence it does. A Danish registry found about a 20% higher risk of recurrent relapses in current hormone users, but the authors say that was driven by an older treatment era before today's high-efficacy MS medicines. It found no link with disability progression.
Is estriol a treatment for MS?
No. Estriol reduced relapses in a 2016 phase 2 trial of younger women taking glatiramer acetate, but it is not an FDA-approved MS treatment and those results don't apply to menopausal HRT.
Is HRT riskier if I use a wheelchair?
It can be. Limited mobility raises blood clot risk, and estrogen pills raise it further. That's a reason to discuss patches, gels or vaginal estrogen, or non-hormonal options, with your clinicians before starting.
Can I use vaginal estrogen if I have MS?
The Cleveland Clinic describes low-dose vaginal estrogen as effective and considered safe in women with MS. It puts far less estrogen into the blood than pills or patches.
Does menopause make MS worse?
The evidence is mixed. A 2025 study of 987 women in the MSBase registry found menopause was not linked with faster disability progression, though an earlier 2015 study suggested it might be. Symptoms like fatigue and bladder problems can feel worse around menopause.
Should I see my neurologist or a menopause doctor first?
If you have new or changing neurological symptoms, start with your neurologist. If your MS is stable, either can be first, as long as both know the plan before you start HRT.
The bottom line
MS does not, by itself, rule out HRT, and MS specialists describe it as generally safe when it suits a woman's own health risks. It isn't a treatment for MS, and the research on MS outcomes is limited. The biggest extra questions are mobility and blood clot risk, which may point toward a patch, gel or vaginal estrogen rather than a pill. The safest path is a plan your neurologist and menopause clinician both know about.
If you're not sure where your care should begin, Find My HRT Path can help you see a featured option or flag when in-person care is the better first step.
Related reading
- Who should not take HRT
- HRT and blood clots
- Oral vs. transdermal estrogen
- HRT and lupus
- Can you take HRT with epilepsy?
- Vaginal estrogen
Sources
All sources were read on October 28, 2026.
- Estradiol tablets (Estrace) prescribing information, contraindications and warnings. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a3803ba3-4eee-4e2e-ac8c-821a4e6720cc
- Aubagio (teriflunomide) prescribing information, section 7. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4650d12c-b9c8-4525-b07f-a2d773eca155
- The Menopause Society. The 2022 hormone therapy position statement. https://menopause.org/wp-content/uploads/professional/nams-2022-hormone-therapy-position-statement.pdf
- Cleveland Clinic Mellen Center. Management of Menopause and Female Sexual Dysfunction in Multiple Sclerosis. https://my.clevelandclinic.org/departments/neurological/depts/multiple-sclerosis/ms-approaches/management-menopause-female-sexual-dysfunction-in-multiple-sclerosis
- MS Society (UK). Menopause and MS. https://www.mssociety.org.uk/living-ms/physical-and-mental-health/menopause-and-ms
- MS Society (UK). Women's health booklet. https://www.mssociety.org.uk/sites/default/files/2020-08/Womens health booklet MSS.pdf
- Kopp TI, et al. Hormone therapy and disease activity in Danish women with multiple sclerosis: a population-based cohort study. European Journal of Neurology, 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9314629/
- Menopause Impact on Multiple Sclerosis Disability Progression. JAMA Neurology, 2025. https://doi.org/10.1001/jamaneurol.2025.3538
- Bove R, et al. A hormonal therapy for menopausal women with MS: a phase Ib/IIa randomized controlled trial. Multiple Sclerosis and Related Disorders, 2022. https://doi.org/10.1016/j.msard.2022.103747
- Voskuhl RR, et al. Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. The Lancet Neurology, 2016. https://doi.org/10.1016/s1474-4422(15)00322-1
- All women with multiple sclerosis should start hormone replacement therapy at menopause unless contraindicated: No. Multiple Sclerosis Journal, 2024. https://doi.org/10.1177/13524585241254987
This page is for education only. It is not medical advice and does not replace care from your own clinicians.